Companies in the Financial sector have received a lot of coverage today as analysts weigh in on Stardust Power (SDST – Research Report) and ...

Organic growth for the spices and sauces maker is still expected to improve on 2024’s 1% pace at the top-end of the forecast ...

Then, at 9 p.m., Trump pulled one over on the partygoers.

Odyssey Therapeutics is a promising biotech firm poised for IPO success with a focus on inflammatory and autoimmune diseases ...

Welcome to the Capital One Q4 2024 earnings call. Please be advised that today's conference is being recorded. After the ...

In a report released today, Andrew Kligerman from TD Cowen maintained a Buy rating on Kemper (KMPR – Research Report), with a price target of ...